US › Healthcare

Innovative Eyewear Inc. (LUCY)

US · Healthcare · Medical Instruments & Supplies

$0.90+4.37%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$1.0M

Revenue YoY

+74.5%

Net profit

$-1.7M

EPS

$-0.26

EPS estimate

$-0.37

Net margin

-165.3%

EPS came in at -0.26 against a street estimate of -0.37 — a beat of 29.7%.

Key statistics

Market cap

$7.2M

Forward P/E

0.0

P/B

1.04

Book value

$1.08

EPS (TTM)

$-1.16

52-week high

$2.24

52-week low

$0.65

50-day MA

$0.84

200-day MA

$1.06

Beta

2.75

Analyst view

Analysts rate Innovative Eyewear Inc. a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $3.00.

Shareholding

Insiders

6.66%

Institutions

8.37%

Largest institutional holders

Fund	Stake
Cetera Investment Advisers	5.81%
Geode Capital Management, LLC	0.70%
Citadel Advisors Llc	0.34%
KeyBank National Association	0.23%
Tower Research Capital LLC	0.02%
JONES FINANCIAL COMPANIES LLLP	0.01%
Wells Fargo & Co	0.00%
Caitong International Asset Management Co., Limited.	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Innovative Eyewear Inc. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.